The Cohere Beauty Strategy: Bridging The Gap Between Concept And Clinical Reality
White Paper

The Cohere Beauty Strategy: Bridging The Gap Between Concept And Clinical Reality

Tatiana Pile

Brands are operating in a high-friction environment defined by saturation, accelerated trend cycles and fragile consumer loyalty. Launching a product isn’t the hard part. Sustaining relevance, credibility and performance over time is. As competitive pressures intensify, the brands that endure are those built on technical rigor alongside a deep understanding of their customers, not just compelling storytelling or new releases.

Within this environment, Cohere Beauty plays a distinct role as a premier contract development and manufacturing organization (CDMO) and strategic innovation partner, supporting some of the industry’s most advanced skincare launches from formulation through scale. With a team of 15 degreed quality control chemists and engineers, 16 research and development (R&D) formulation scientists, two PhD scientists and decades of formulation expertise, Cohere Beauty has positioned itself at the forefront of the “skinflection point,” the threshold where true innovation is shifting from marketing-driven claims to science-backed products that prove efficacy and biomimetic delivery systems.

Cohere Beauty matters because it has effectively addressed three of the most crucial challenges brands face today:

    • Navigating Skincare Innovation and Choosing the Right CDMO: Modern skincare has reached a level of complexity where clinical is no longer a luxury differentiator, but a nonnegotiable requirement for entry. As such, the challenge for brands isn’t just finding a unique and creative concept, but offering products with proven efficacy and an infrastructure capable of managing the scientific and regulatory hurdles of a post-Modernization of Cosmetics Regulation Act (MoCRA) world. Cohere Beauty delivers this by partnering as a strategic R&D extension rather than a traditional manufacturer. 
    • A Deep Dive on Ingredient and Category Trends: As consumer demand shifts toward skinification, biotech-driven actives and wellness-adjacent benefits, brands face growing pressure to make smarter, earlier R&D bets. The challenge is no longer identifying trends once they are established, but determining which ingredients, formats and claims have the technical and commercial potential to scale before they become ubiquitous.
      To address this, Cohere Beauty has built an internal Innovation Library designed to translate emerging science into formulation-ready concepts. Rather than reacting to market trends, the team continuously pre-develops product frameworks across ingredients, delivery systems and categories, informed by clinical data, ingredient sourcing and regulatory viability. For brands, this approach reduces uncertainty and compresses development timelines, enabling them to move directly into refinement and differentiation instead of navigating prolonged trial-and-error cycles.
    • The Future of Skincare Innovation: Clinicals, AI and Innovation-First Brands: The industry is moving away from the growth-at-all-costs mindset toward a demand for both strong profit margins and efficacy. Today, credible testing and data-driven proof points are essential to win over retailers and investors. For the next generation of brands, the focus will be on how to accelerate speed to market without sacrificing the integrity of the results. Cohere Beauty is redefining this future by merging artificial intelligence with disciplined clinical standards. By leveraging AI platforms for predictive stability and formulation modeling while maintaining a strict four-to-five month clinical window, Cohere Beauty builds innovation-first brands rooted in proven performance and technical excellence.

In this white paper, the first of a three-part series, we have examined how Cohere Beauty is leveraging its technical infrastructure and R&D expertise to help brands navigate the intense scientific and regulatory hurdles of the modern skincare market. We look at Cohere Beauty’s perspective on how brands should assess CDMO partners in an increasingly technical and competitive landscape and the specific capabilities required to turn ambitious concepts into successful, clinical-grade launches. The second white paper will provide a deep dive into the evolving ingredient and category forces, from biotech-driven actives to wellness-adjacent launches, shaping tomorrow’s hero products. The third paper will explore the future of skincare innovation, focusing on the baseline necessity of clinical validation and the transformative role of artificial intelligence in formulation and brand building.

How Cohere Beauty is reshaping the industry through cutting-edge R&D and product concepts

Section 1: The New Innovation Standard

Beauty has reached an inflection point where incremental updates no longer drive differentiation, forcing brands to pursue deeper, more transformative forms of innovation to remain competitive. As Jami Mitchell, director of R&D at Cohere Beauty, says, “Innovation in skincare is shifting from marketing-driven claims to science-backed breakthroughs. We’re entering a period where true innovation will come from the convergence of advanced biotechnology, more sophisticated ingredients and a higher standard for clinical validation.”

Specifically, truly transformative innovation is being driven by the rise of next-generation peptides, postbiotic microbiome modulators, bioengineered delivery systems and mRNA-inspired actives that offer high performance without the trade-off of skin irritation. What used to be considered clinical will soon be just table stakes. Every brand, regardless of price point, will need robust, well-designed clinical studies to substantiate its claims as the industry moves away from loosely structured, supplier-driven protocols toward real-world performance data. 

To bridge this gap, Cohere Beauty provides a strategic R&D partnership that goes beyond the scope of a standard contract manufacturer. While clinical testing is not conducted in-house, Cohere Beauty supports brands by leveraging raw material supplier data packages to substantiate ingredient-led performance and align formulas with appropriate claim language. For brands requiring higher-vigor validation, Cohere Beauty also maintains partnerships with independent clinical testing laboratories, connecting its customers with the right testing partner and protocol for their goals, ranging from basic consumer use studies and instrumental testing to robust clinical trials, to ensure finished-product claims meet the rigor that the market, retailers and consumers now expect.  

Section 2: The Strategic R&D Partnership

Choosing a CDMO isn’t just about manufacturing; it’s about securing a long-lasting strategic partnership. Many brands underestimate the technical demands and sheer expense of innovation. Even before a single product ships, it can cost upwards of $25,000 or more to build one SKU, accounting for marketing spend, creative development, safety and stability testing, regulatory submissions, clinical studies and the operational lift needed to scale. 

“A true innovation partner does far more than just develop formulas,” says Jami Mitchell, director of R&D at Cohere Beauty. “Cohere wants to be the one that shares the insights, challenges customer briefs and brings forward newly emerging opportunities that help elevate a brand strategy while also making sure that Cohere is aligning functional teams internally from the start and communicating with transparency, accountability and speed.”

Cohere Beauty reinforces this partnership through:

    • R&D Bench Depth: Cohere Beauty currently maintains a team of over 15 specialized chemists, including experts with years of “on bench” experience in skincare applications. These experts solve complex formulation issues and eliminate the technical gaps that can occur when brands lack in-house chemistry expertise. 
    • Regulatory Bandwidth: Cohere Beauty has doubled the size of its internal regulatory department to manage the massive operational lift required for global compliance and new standards like MoCRA.  
    • Predictive AI: Cohere Beauty utilizes AI-driven platforms to call out potential ingredient interactions early, speeding up time to market without sacrificing safety.

Meet Cohere’s Chemists

As a former student of the University of Nebraska at Lincoln and current student at the University of Nebraska at Omaha, Oscar Huang has a background in biochemistry revolving around animal and human health in genomics. Huang adds that transitioning into cosmetic chemistry proved to be the most rewarding decision of his journey, revealing layers of the cosmetics world he would never have encountered otherwise. When he’s not in the lab and has free time, Huang enjoys spending time with family and gaming with friends.

“My favorite product that I have created and am most proud of was a shower jelly that revolves around eco-friendly raw materials, unique sensory experiences, while also appealing to the younger audience,” he says. “The jelly is used like a traditional bar of soap without stripping the natural oils off your body, leaving it moisturized.”

 

 

 

Dr. Jenae Linville earned her undergraduate degree in chemistry from Grand Valley State University in Michigan where she also competed in hammer and discus throw events on the university’s track and field team. Linville went on to complete her PhD in organic chemistry at The Ohio State University, where her research focused on peptides and complex molecular design. She has worked across the beauty category, including biomedical devices, nail care and personal care products, ultimately finding her passion in creating innovative, science-backed products consumers truly love. Now a manager at Cohere Beauty, Linville blends technical expertise with creativity to develop impactful solutions. Since moving to Phoenix with her husband, she has embraced the Arizona lifestyle through hiking and exploring the desert’s natural beauty and recently became a proud mom to a baby boy.

“My favorite products I’ve created are an innovative shampoo and leave-in conditioner duo designed to strengthen hair while delivering weightless nourishment and smoothness without the grease so many products leave behind. Inspired by my own frustration with formulas that made my hair look oily even after showering, I developed a system that cleanses, reinforces strands from root to tip and deeply hydrates using lightweight ingredients,” she says. “The result is stronger, softer, visibly smoother hair with natural shine and movement.”

 

Sara Rockwell’s background includes eight years of experience in QA/QC and formulation within an industrial lubricants laboratory, where one of her favorite responsibilities was conducting used-oil analysis to help customers identify issues and anticipate potential engine problems. Before entering the sciences, Rockwell earned a fine arts degree and briefly worked in marketing before finding her way back to Quality Assurance in the health supplement industry.

According to Rockwell, advancing her career at Cohere Beauty has been the most fulfilling step in her professional journey. She loves being back in the lab creating, analyzing and developing innovative personal care products that make an impact.

“My love of art and creativity naturally fuels my curiosity about color, especially when it comes to natural pigments,” she says. “I’m always on the lookout for the latest plant‑based or mineral pigments hitting the market, eager to get them into the lab, so I can explore their light stability, vibrancy and overall color payoff. There’s something incredibly exciting about blending science with artistry and discovering how nature can bring new depth and dimension to cosmetic formulations.”

 

Karen Saavedra is an Omaha native who has been with Cohere Beauty for over four years. A biology graduate of College of Saint Mary in Nebraska, she previously worked in healthcare taking care of elderly patients and as a pharmaceutical technician. Saavedra enjoys the blend of science and creativity behind R&D formulation and how there’s always room for learning and growth. Outside of work, she enjoys reading and collecting books, drawing and spending time with her husband and their cat Bijou.

“One of my favorite projects to work on was a gommage cleansing balm. Its unique gel texture melts into a luxurious oil on the skin, then, when in contact with water, transforms into a milky rinse with gentle rice-based exfoliants,” she says. “It’s a very fun sensory experience and, of course, has the benefit of thoroughly cleansing and refining skin texture.”

Step 3: Balancing Speed with Scientific Rigor 

While speed-to-market is critical, innovation requires time, specifically for clinical validation.

“Designing and executing meaningful clinical studies can take four to five months—or even longer—depending on the level of rigor, the endpoints you’re measuring and the unique goals of each product,” says Christine Staples, CEO of Cohere Beauty. “Brands don’t always realize that every product may require its own study design if they want claims that are truly substantiated.”

What’s more, brands often overlook the risk of single-sourcing ingredient supplies for novel and trending actives, which can derail a launch if not strategically secured through a dual-source supply for reliability. 

To bridge this gap, the Innovation Library allows brands to start creatively with textures and sensory profiles while knowing the underlying formulation is already technically sound and scalable. This library approach allows the team to take names out of it and help brands focus on textures, creative and crossover opportunities before they are predefined by a narrow category like hair, skin care or fragrance.

KEY TAKEAWAYS

  • Move from vendor to R&D extension: The most successful brands use their CDMO as a direct extension of their own team, not just a service provider. This collaboration thrives on transparency and trust, creating a space where challenges such as light modifications, timeline shifts or cost analysis are embraced together to create a solution instead of met with a simple no.
  • Solid infrastructure over “idea-only” strategy: One of the biggest gaps in product development occurs when a brand lacks its own chemistry expertise. Brands must ensure their vision is supported by a strong technical backbone. By partnering with a CDMO that has a deep bench of experienced chemists, it ensures that marketing concepts and launches are grounded in formulation reality, preventing costly late-stage missteps. 
  • Build on a regulatory foundation: In a global market, regulatory compliance is foundational to growth and the ultimate insurance policy. Brands should seek CDMO partners who proactively manage regulatory shifts like tightening rules around fragrance components and allergens and dioxane and surfactants, allowing the brand to scale safely into new regions and territories without the risk of “stop sale” orders or costly reformulations. 
  • Invest in efficacy: As clinical becomes the baseline, brands must look toward the next frontier—precision peptides, microbiome modulators, and biomimetic delivery systems—to truly set themselves apart. By using Cohere Beauty’s pre-vetted Innovation Library, brands can prioritize high-performance formats, ingredients and formulations that have already cleared the initial hurdles of stability and scalability in two or three rounds of iterations.